Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MET variants with activating N‐lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation

Molecular Oncology(2025)10.1002/1878-0261.13806Source: DataRank Database

MET variants with activating N‐lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation is a research paper published in Molecular Oncology (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

cellosaurus pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.17)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Audrey Vinchent,Marie Fernandes ORCID,Isabelle Damour,Agathe Laratte,Rémi Tellier ORCID

Live enrichment

PubMed:39980226 PMC:PMC12330938 OpenAlex:https://openalex.org/W4407828321

National Institutes of Health

Grant: CA239604

NCI NIH HHS

Grant: R01 CA239604

Contrat de Plan Etat Region CPER Cancer 2015-2020

Institut National Du Cancer

Ligue Contre le Cancer, Comités Nord et Aisne

Cancéropôle Nord-Ouest

Institut National du Cancer

SIRIC ONCOLille

Agence Nationale de la Recherche

Ligue Contre le Cancer

FWCI

1.17

Citation Percentile

0.8%

Citation Trend

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13806

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13806

publisherhttps://febs.onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13806

publisherhttps://febs.onlinelibrary.wiley.com/doi/full-xml/10.1002/1878-0261.13806

journalhttps://doi.org/10.1002/1878-0261.13806

Fields of Study

Renal and related cancersRenal cell carcinoma treatmentLiver physiology and pathology

MeSH Terms

AnimalsCarcinoma, Renal CellFemaleHumansKidney NeoplasmsLigandsMaleMutationSignal TransductionHepatocyte Growth FactorProto-Oncogene Proteins c-metCell Line, TumorMice

Keywords

StimulationCancer researchMutationClear cellCellLigand (biochemistry)BiologyMedicinePathologyReceptorChemistryInternal medicineGeneticsRenal cell carcinomaGeneCancerReceptor tyrosine kinaseHepatocyte growth factorMetSomatic MutationsHereditary Papillary Renal Cancer

Sustainable Development Goals

SDG 0: Good health and well-being

MET variants with activating N‐lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation

FAIR Checklist

Authors (15)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)